CLDI CLDI
Company Profile ↓Company Overview
CLDI (CLDI) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -75.27% |
| 6 Months: | -88.81% |
| 3 Months: | -48.11% |
| 1 Month: | -23.61% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)43.20 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 98.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -83.30K | -1.09M | -528.86K | -361.62K | -6.99M | -5.41M | -6.54M | -7.22M | -6.75M | -5.77M | -5.23M | -5.06M | -5.66M | -5.05M | -4.19M |
| Net Income | -83.30K | -823.29K | -7.74M | -4.58M | -5.36M | -6.46M | -12.50M | -2.02M | -7.22M | -5.77M | -5.05M | -4.99M | -5.71M | -5.15M | -4.11M |
| Diluted EPS | - | - | - | - | -0.63 | -0.75 | -14.24 | -1.41 | -2.03 | -16.75 | -7.75 | -2.21 | -1.99 | -2.21 | -0.43 |
| R&D Expense | - | - | - | - | 1.95M | 2.62M | 3.18M | 3.25M | 2.74M | 2.17M | 2.15M | 2.42M | 2.59M | 2.36M | 2.59M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 45.00K | - | - | - |
| Operating Income | -23.13M | -28.99M | -21.78M | -20.24M |
| Net Income | -25.43M | -29.22M | -22.14M | -19.91M |
| Diluted EPS | 2.99 | -17.33 | -35.70 | -5.95 |
| R&D Expense | 7.26M | 13.01M | 8.88M | 9.74M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 231.77M | 2.60M | 10.02M | 14.18M | 8.86M |
| Total Equity | 0 | -31.61M | -50.44M | -8.23M | 1.53M | 3.76M |
| Cash & Equivalents | - | 1.06M | - | - | 9.60M | - |
| Long Term Debt | - | - | - | 2.06M | 600.00K | 600.00K |
| Total Liabilities | - | 16.45M | 43.44M | 18.25M | 12.21M | 5.10M |
| Current Liabilities | - | 410.99K | 42.99M | 10.23M | 9.50M | 3.94M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -13.21M | -26.98M | -19.69M | -21.29M |
| Investing Cash Flow | -494.00K | -478.00K | -16.00K | -170.00K |
| Financing Cash Flow | 12.09M | 29.04M | 27.36M | 17.46M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | -51,395.6% | - | - | - |
| Net Margin % | -56,504.4% | - | - | - |
| ROE % | 50.4% | 354.8% | -1,443.5% | -529.6% |
| ROCE % | 57.3% | 13,611.3% | -464.7% | -411.2% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CLDI
Calidi shareholders will get one share for every 16 held - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNMnZJTUFiSVVCSmlFZXhZYmIxWXRyRlpmYWxGZjlnYXR4SWh5UFlMNnR1THNLWk1rZl9adE41eFN0Yk1WNlpsbWVERVBzVUEtYU8xdWNkTUc0U3FNRXRJTXY3VEZIczdrcmh3R3BqYUxFTk1WMTNSd3F1SFJhNEUxcGc5MlRRWC0wX0R4c0…
Calidi Biotherapeutics Inc. (NYSE: CLDI) Share Price, CLDI Stock News, CLDI Share Price & Updates - Kalkine
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE8wVldMM2VVaWo1Yzh4WG1na2V0a19Na1ZqMGJnbUJaMndlb05ENi0xQjNBUmtJdFpac215LUtNeU10OXFGQnpWQmR1NGtxTmIzdng0?oc=5" target="_blank">Calidi Biotherapeutics Inc. (NYSE: CLDI) Share Price, C…
Calidi Biotherapeutics To Carry Out 1-for-16 Reverse Stock Split On July 31st, 2026 - Moomoo
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQZE05bjk4cU0wTTNwZjg0WHEzdkRZR3ZydGh3ZmF2UXBvUmNUa3FPdExsX2FQcGxDdWlnZ1daTHJBd1Z5ZHBfeHUweDZBTVJNZl9oRG9WZDhKdDdfNXZPWTBlR0NSSk1VemRsYk1aOFRsNjJKVUp2TThBS19yS3k3ZTBab09iaGxQd3lNd1…
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026 - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxNY0dHYzdYbTREaldWS0llN3JMekZkOFpabDJSbUthbENrU0hmNHNkUnI4cGs4ZnJXLXZMenZFLUVLVkRwbmZJQmRnV3l6dWRUaF9YZnF0UHpHWlJWazFmSTQyOUZXN3ZLaUNiT3c0Rk1aRzlSTTdFZzRSdDc5cWRJU1ZiWDN4Qk44azNzS2…
Calidi Biotherapeutics, Inc. Issues Financial Statement Audit Report Highlighting Going Concern Assumption - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNWHJKQjBFQ21iX3BnQUVFdzMyVWViUS1xS1VDWEhIQlkzMGxCQ1M3V3VVWjYyck4waXhaeWtxLVhaWGNRYVNZbEtoYWFNRXZJRVZqU2lLWVpBTDVVV3BNTHJyS2NBYmZJZnYzZ3NRcmNKa0Z2STRwZFRBcmo4MERfZ3dJVjZJZlVlcl9BWm…
Calidi Cut G&A by About $1M; Targets First Dose in Q1 2027 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbnlWUnpzWlVMQ295V3ZsYXJWU3o0OEY4bFEzWmljZWNqVUZ4Z3lDMDJPUnlVY19fbVF5T3RINjFyb1VVQV9wLWV4TDl3cW9HTGQwOFQ3YmNsOUxnN0pRRG03Q09fOFVFNzlfaDg2YXVvRkcyYXAwNkREVzJhUHU0R1R4RG91d1o1c0FzR1…
CLDI — Frequently Asked Questions
What is the current share price of CLDI?
As of 2026-08-05 17:25 PDT, CLDI trades at $1.76 on NASDAQ/NYSE. Its 52-week range is $1.49 to $116.00.
What is the P/E ratio of CLDI?
CLDI trades at a trailing price-to-earnings (P/E) ratio of -0.30.
Is CLDI a good stock to buy?
This page provides a data-driven analysis of CLDI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.